Cancer Diagnostics Market Growth Opportunities: Insights from 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Anticipated Size Of The Cancer Diagnostics Market Over The Five-Year Period 2025–2029?

The dimension of the cancer diagnostics sector experienced substantial augmentation over the past few years, projecting a rise from its valuation of $23.24 billion in 2024 to an anticipated $25.5 billion in 2025, reflecting a consistent annual expansion rate, or CAGR, of 9.7%; this acceleration during the past period is directly linked to the heightened frequency of cancer cases, expanded screening initiatives, the progression of bespoke medical treatments, and greater public cognizance regarding the disease.

Anticipated for swift expansion over the immediate future, the segment dedicated to cancer diagnostics is projected to reach a valuation of $40.07 billion by 2029, achieving a compound annual growth rate (CAGR) of 12.0%; this upward trend during the projection timeframe stems from several factors, including the expansion within developing markets, supportive governmental regulations, advancements in artificial intelligence (AI) and machine learning technologies, alongside an increased focus on identifying diseases at earlier stages and initiating prompt treatments, while key developments shaping this period involve the rise of liquid biopsies, the integration of multi-omics methodologies, a shift towards point-of-care testing options, and the ongoing implementation of campaigns centered on screening and preventative early intervention measures.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

What Are The Key Drivers Of Growth In The Cancer Diagnostics Market?

The widespread occurrence of numerous cancer types significantly propels the growth of the cancer diagnostics market, stemming from the fact that rising cancer diagnoses prompt more individuals to seek both detection and subsequent therapeutic interventions. Furthermore, the World Health Organization (WHO) reports that cancer stands as the second primary global cause of mortality, and projections from the National Cancer Institute (NCI) suggest that annual new cancer diagnoses are anticipated to climb to 23.6 million before the year 2030 arrives.

What Are The Segment Types Shaping The Cancer Diagnostics Market?

The cancer diagnosticsmarket covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

What Are The Major Trends Driving The Growth Of The Cancer Diagnostics Market?

Within the cancer diagnostics landscape, a notable movement is the integration of Artificial Intelligence, which serves to enhance the precision of image analysis during diagnostic procedures like those for breast and lung malignancies by identifying cancers at their nascent stages. Furthermore, the application of AI leads to fewer incorrect positive results in screenings for lung cancer, thereby boosting the overall accuracy of this detection. As an illustration, a dependable system, featuring algorithms designed for the independent assessment of lymph node biopsies, was created through a collaboration between investigators at the Naval Medical Center San Diego and Google AI; this specific AI innovation successfully elevated the precision of identifying metastatic breast cancer to an impressive ninety-nine percent.

Who Are The Primary Competitors In The Global Cancer Diagnostics Market?

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic plc, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

How Is Cancer Diagnostics Market Demand Varying Across Different Regions?

North America was the largest region in the cancer diagnostics market in 2024. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The Cancer Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Browse Through More Reports Similar to the Global Cancer Diagnostics Market 2025, By The Business Research Company

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795